Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.025 USD | -4.03% | -7.14% | -39.49% |
May. 13 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
May. 09 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.49% | 242M | |
+10.45% | 115B | |
+12.13% | 106B | |
-6.72% | 24.69B | |
-1.14% | 21.97B | |
-4.97% | 19.27B | |
-12.05% | 17.56B | |
-39.36% | 17.32B | |
+5.39% | 14.03B | |
+33.16% | 12.13B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Transcript : Coherus BioSciences, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-11-2023 10